The role of STI testing in menopause is clinically relevant but not directly addressed in the provided context. During menopause, hormonal shifts can increase vaginal vulnerability, and new or multiple sexual partners may still pose infection risks. However, routine STI screening is not universally recommended for all menopausal women without specific risk factors. The evidence base in the given material is weak, so we classify this as 'unclear'. Direct-to-consumer STI tests have limited accuracy compared to clinical lab tests. Important caveat: STI testing does not replace cervical cancer screening (HPV/Pap). Safety note: any unusual symptoms (discharge, pain) warrant medical evaluation. Overall, while STI testing can be part of a comprehensive health assessment in menopause, it is not a core component unless indicated by history or symptoms.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-0a45263655f6a10a8c91f686